• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    3/28/24 2:08:52 PM ET
    $ABTS
    $AKAN
    $ALLG
    $ALT
    Computer Software: Programming Data Processing
    Technology
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $ABTS alert in real time by email

    Shares of Kodiak Sciences Inc. (NASDAQ:KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss.

    Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

    Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares jumped 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) gained 146% to $1.58 after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares climbed 80% to $1.5395. Biodexa's MTX110 showed promise in extending life expectancy against aggressive brain cancers.
    • Ontrak, Inc. (NASDAQ:OTRK) gained 55% to $0.9239.
    • Binah Capital Group, Inc. (NASDAQ:BCG) gained 48% to $14.05 after dipping more than 20% on Wednesday.
    • Kidpik Corp. (NASDAQ:PIK) gained 40.7% to $4.5999. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement.
    • Allego N.V. (NASDAQ:ALLG) rose 32.8% to $1.7650.
    • Akanda Corp. (NASDAQ:AKAN) gained 28% to $0.2053 after the company announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry.
    • Destiny Tech100 Inc. (NASDAQ:DXYZ) rose 26% to $22.15.
    • REX American Resources Corporation (NYSE:REX) gained 23.2% to $54.15 following upbeat earnings.
    • Nutriband Inc. (NASDAQ:NTRB) gained 23% to $4.98. Nutriband recently provided a clinical and regulatory path overview for its AVERSA Fentanyl patch.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) gained 22.8% to $4.6050.
    • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) gained 22.7% to $2.00.
    • Hut 8 Corp. (NASDAQ:HUT) gained 20.4% to $11.87. Hut 8 Corp reported revenue of C$60.6 million for the six months ended Dec. 31, 2023.
    • Matterport, Inc. (NASDAQ:MTTR) rose 16.8% to $2.2802.
    • RH (NYSE:RH) rose 16.2% to $344.99 following the release of quarterly results. RH posted weaker-than-expected results for its fourth quarter, but issued upbeat forecast.
    • Cazoo Group Ltd (NASDAQ:CZOO) gained 15.5% to $14.52 after jumping over 100% on Wednesday.
    • Sutro Biopharma, Inc. (NASDAQ:STRO) surged 14.4% to $5.64. Oppenheimer analyst Jay Olson maintained Sutro Biopharma with an Outperform and maintained a $10 price target.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares rose 14.1% to $0.1021. Kintara Therapeutics announced expansion of REM-001 clinical study to include patients on pembrolizumab.
    • Nikola Corporation (NASDAQ:NKLA) gained 12.7% to $1.0250.
    • OPKO Health, Inc. (NASDAQ:OPK) climbed 12.1% to $1.1996. Labcorp announced acquisition of select assets of BioReference Health's Diagnostics Business.
    • Altimmune, Inc. (NASDAQ:ALT) climbed 11.4% to $9.90. Altimmune recently released lean mass preservation data for pemvidutide and worse-than-expected fourth-quarter FY23 earnings.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) gained 10.4% to $24.37.
    • Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) rose 7.1% to $1.1786. Ginkgo Bioworks announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency.
    • The Estée Lauder Companies Inc. (NYSE:EL) gained 5.4% to $152.85 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $160 to $170.

    Losers

    • Primech Holdings Ltd. (NASDAQ:PMEC) shares fell 46.7% to $2.07 after the company issued financial updates and corporate highlights for the six months ended Sept. 30, 2023.
    • Gamida Cell Ltd. (NASDAQ:GMDA) fell 28.1% to $0.0427. Gamida Cell shares dipped over 82% on Wednesday after the company reported fourth-quarter results and disclosed the commencement of a restructuring process.
    • Data Storage Corporation (NASDAQ:DTST) dipped 24% to $5.81 following fourth-quarter results.
    • urban-gro, Inc. (NASDAQ:UGRO) declined 22.9% to $1.3992 after the company reported worse-than-expected fourth-quarter financial results.
    • Presto Automation Inc. (NASDAQ:PRST) fell 22% to $0.1493. Presto Automation recently entered securities purchase agreements relating to the issuance and sale of 4.8 million shares
    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) dipped 19.6% to $0.2629. Tonix Pharmaceuticals announced pricing of $4.4 million registered direct offering.
    • MillerKnoll, Inc. (NASDAQ:MLKN) shares fell 17.2% to $25.28 as the company reported downbeat sales for its third quarter and issued weak guidance for the fourth quarter.
    • Sezzle Inc. (NASDAQ:SEZL) fell 16.6% to $77.13.
    • NuCana plc (NASDAQ:NCNA) fell 16.3% to $0.2616. NuCana announced a plan to implement 1-for-25 ADS ratio change.
    • SOBR Safe, Inc. (NASDAQ:SOBR) fell 13.7% to $0.4460 after gaining 12% on Wednesday.
    • Murano Global Investments Plc (NASDAQ:MRNO) fell 13% to $12.97.
    • 22nd Century Group, Inc. (NASDAQ:XXII) fell 12.5% to $ 0.1151 as the company posted fourth-quarter results and announced stock split of 1-for-16.
    • MicroStrategy Incorporated (NASDAQ:MSTR) declined 10.9% to $1,710.01.
    • Hitek Global Inc. (NASDAQ:HKIT) fell 10.3% to $1.56 after gaining over 22% on Wednesday.
    • Movella Holdings Inc. (NASDAQ:MVLA) fell 10.2% to $0.0678 after dipping 20% on Wednesday.
    • Abits Group Inc. (NASDAQ:ABTS) fell 10.2% to $0.70.
    • Reddit, Inc. (NYSE:RDDT) fell 9.4% to $52.32.
    • Braze, Inc. (NASDAQ:BRZE) dipped 9.3% to $45.90 after the company issued soft EPS guidance for FY25.
    • The Chemours Company (NYSE:CC) shares dropped 6.2% to $27.09 after the company reported fourth-quarter results. The company also said it identified four material weaknesses amid its internal control over financial reporting.
    • GCT Semiconductor Holding Inc, (NYSE:GCTS) fell 5.1% to $41.77 amid volatility following the company's recently completed business combination with Concord Acquisition Corp III and NYSE debut.
    • Carnival Corporation & plc (NYSE:CCL) fell 4% to $16.52. Carnival posted a narrower-than-expected loss for its first quarter on Wednesday.

     

    Now Read This: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'

    Get the next $ABTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABTS
    $AKAN
    $ALLG
    $ALT

    CompanyDatePrice TargetRatingAnalyst
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    Sezzle Inc.
    $SEZL
    2/12/2026$85.00Buy
    Needham
    MillerKnoll Inc.
    $MLKN
    2/10/2026Outperform
    William Blair
    Estee Lauder Companies Inc.
    $EL
    2/10/2026$106.00Buy → Hold
    HSBC Securities
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Reddit Inc.
    $RDDT
    2/6/2026$245.00 → $250.00Buy
    B. Riley Securities
    Estee Lauder Companies Inc.
    $EL
    2/6/2026$120.00Neutral → Buy
    Citigroup
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    More analyst ratings

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MARA Holdings Inc. downgraded by H.C. Wainwright

    H.C. Wainwright downgraded MARA Holdings Inc. from Buy to Neutral

    2/27/26 11:05:23 AM ET
    $MARA
    EDP Services
    Technology

    Needham initiated coverage on Sezzle with a new price target

    Needham initiated coverage of Sezzle with a rating of Buy and set a new price target of $85.00

    2/12/26 7:13:35 AM ET
    $SEZL
    Finance: Consumer Services
    Finance

    William Blair initiated coverage on MillerKnoll

    William Blair initiated coverage of MillerKnoll with a rating of Outperform

    2/10/26 8:01:31 AM ET
    $MLKN
    Office Equipment/Supplies/Services
    Consumer Discretionary

    $ABTS
    $AKAN
    $ALLG
    $ALT
    SEC Filings

    View All

    SEC Form S-8 filed by SOBR Safe Inc.

    S-8 - SOBR Safe, Inc. (0001425627) (Filer)

    2/27/26 5:14:59 PM ET
    $SOBR
    Newspapers/Magazines
    Consumer Discretionary

    SEC Form DEFM14A filed by Carnival Corporation

    DEFM14A - CARNIVAL CORP (0000815097) (Filer)

    2/27/26 4:16:55 PM ET
    $CCL
    Marine Transportation
    Consumer Discretionary

    SEC Form 424B3 filed by Carnival Corporation

    424B3 - CARNIVAL CORP (0000815097) (Filer)

    2/27/26 4:14:34 PM ET
    $CCL
    Marine Transportation
    Consumer Discretionary

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Scientific Officer Roberts M Scot

    4 - Altimmune, Inc. (0001326190) (Issuer)

    2/27/26 4:10:07 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Financial Officer Weaver Gregory L

    4 - Altimmune, Inc. (0001326190) (Issuer)

    2/27/26 4:05:36 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SVP, GC & Corp. Secretary Wellman Kristine M was granted 1,781 shares and covered exercise/tax liability with 675 shares, increasing direct ownership by 2% to 51,402 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    2/26/26 6:00:08 PM ET
    $CC
    Major Chemicals
    Industrials

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    First Towers & Fiber Corp. Owns the Largest Dark Fiber Network in Central Mexico

    Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - Akanda Corp. (NASDAQ:AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today plans to further expand the leasing of its approximately 700-kilometre dark fiber optic network located in Central Mexico. The network represents the largest dark fiber infrastructure in the region, serving several of Mexico's most active industrial corridors and fastest-growing state economies.The network was constructed following the execution of a 20-year long-term dark fiber lease agreement with Telefónica, the Spanish multinationa

    2/27/26 8:30:00 AM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

    MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11th. Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative. About OPKO Health OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization

    2/27/26 8:00:00 AM ET
    $OPK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Summit Therapeutics to Present at Upcoming Investor Conferences

    Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today announced that it will participate in three upcoming investor conferences during March of this year. Members of the Summit leadership team will participate in individual investor meetings along with some fireside chats at the following conferences: TD Cowen's 46th Annual Health Care Conference in Boston on Monday, March 2, 2026 Fireside chat 2:30pm ET Jefferies Conference in Miami on Tuesday, March 10, 2026 Investor meetings only Citizens Life Sciences Conference in Miami on Wednesday, March 11, 2026 Fireside chat 2:15pm ET The fireside chats will be available live on our website: www.

    2/26/26 6:45:00 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABTS
    $AKAN
    $ALLG
    $ALT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    April 17, 2023 - FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

    For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers p

    4/17/23 1:02:15 PM ET
    $GMDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/18/21 5:24:40 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Farrell Sarah E bought $7,482,139 worth of shares (50,500 units at $148.16) (SEC Form 4)

    4 - Reddit, Inc. (0001713445) (Issuer)

    2/12/26 7:52:22 PM ET
    $RDDT
    EDP Services
    Technology

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Pisano Wayne bought $20,410 worth of shares (5,000 units at $4.08), increasing direct ownership by 59% to 13,498 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    1/9/26 4:10:05 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Leadership Updates

    Live Leadership Updates

    View All

    CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, announces the appointment of Eric Francois to the Company's Board of Directors. "Eric's decades of financial, transactional and operational experience will make an immediate impact to CERo's board of directors," said Chris Ehrlich, Company Chairman and Chief Executive Officer. "Furthermore, his expertise in capital raising, M&A, and business development will be an impactful addition at this stage of our development." Mr. Francois is an executive with over 25

    2/17/26 8:00:00 AM ET
    $CERO
    $CRVO
    $SCYX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Sezzle Announces Chief Financial Officer Transition

    Minneapolis, MN, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Sezzle, a purpose-driven digital payment platform, today announced the appointment of Lee Brading as Chief Financial Officer ("CFO"), effective February 1, 2026. Brading will succeed Karen Hartje, who served as CFO and principal financial officer under a Consulting Agreement since November 1, 2025, following her announcement of retirement after nearly eight years as CFO of Sezzle. Hartje will remain engaged as a consultant to ensure an orderly transition.  "Karen has been instrumental in Sezzle's evolution from a private startup to a publicly traded, profitable fintech company," said Char

    1/29/26 4:14:17 PM ET
    $SEZL
    Finance: Consumer Services
    Finance

    MillerKnoll Appoints Former J. Jill CEO Claire Spofford to Board of Directors

    ZEELAND, Mich., Jan. 16, 2026 /PRNewswire/ -- MillerKnoll (NASDAQ:MLKN), a growth-oriented small-cap value company in the industrial and consumer sectors, today appointed Claire Spofford to its Board of Directors. An accomplished retail executive with more than 30 years of experience driving growth across leading consumer brands, Spofford brings deep expertise in omnichannel strategy, brand development, and operational excellence. She most recently served as President and Chief Executive Officer of J. Jill, where she helped transform the business, strengthened margins and refr

    1/16/26 4:05:00 PM ET
    $MLKN
    Office Equipment/Supplies/Services
    Consumer Discretionary

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/10/24 6:06:03 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:41 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Financials

    Live finance-specific insights

    View All

    Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

    Ginkgo provides an update on its fourth quarter financial resultsBOSTON, Feb. 26, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA, ", Ginkgo", )) today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with additional details on the third quarter, as well as supplemental financial information will be available at investors.ginkgobioworks.com. Fourth Quarter 2025 Financial ResultsFourth quarter 2025 Total revenue of $33 million compared to $44 million in the comparable prior year pe

    2/26/26 4:26:00 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    MARA Announces Fourth Quarter and Fiscal Year 2025 Results

    Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a leading energy and digital infrastructure company, today announced its preliminary, unaudited fourth quarter and fiscal year 2025 financial results in a letter to shareholders. Investors are invited to access the fourth quarter 2025 shareholder letter at MARA's website at ir.mara.com. A copy of the letter will also be furnished to the Securities and Exchange Commission on a Form 8-K. MARA will hold a webcast and conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) today to discuss these financial results. To register to participate in the conference call, please use

    2/26/26 4:20:00 PM ET
    $MARA
    EDP Services
    Technology

    MARA Announces Strategic Partnership with Starwood to Accelerate Delivery of Cutting Edge Hyperscale, Enterprise and AI Capable Digital Infrastructure

    Joint Platform Expected to Deliver Approximately 1 GW of Near-Term IT Capacity, with Pathway to More than 2.5 GW  Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ:MARA), a leading energy and compute infrastructure company, today announced it has entered into a strategic agreement with Starwood Capital Group ("Starwood") and their dedicated data center development platform Starwood Digital Ventures ("SDV"). The partnership will enable the conversion and expansion of select MARA sites into next generation digital infrastructure capable of meeting the growing demand from enterprise, hyperscale and AI customers. Together, MARA and Starwood will jointly develop, financ

    2/26/26 4:15:00 PM ET
    $MARA
    EDP Services
    Technology

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary